Abstract
Autism is a severe childhood disorder already presenting in the first 3 years of life and, therefore, strongly correlated with neurodevelopmental alterations in prenatal, as well as postnatal period. Neurotransmitters hold a pivotal role in development by providing the stimulation needed for synapses and neuronal networks to be formed during the critical period of neuroplasticity. Aberrations of the serotonergic system modify key processes in the developing brain and are strongly implicated in the pathophysiology of developmental disorders. Evidence for the role of serotonin in autism emerges from neuropathological, imaging and genetic studies. Due to its developmental arrest, autism requires early intervention that would, among others, target the disrupted serotonergic system and utilize brain plasticity to elicit clinically important brain changes in children.
Keywords: Autism, serotonin, serotonergic, developmental intervention, plasticity, 5-hydroxytryptophan
Current Neuropharmacology
Title: The Serotonergic System: Its Role in Pathogenesis and Early Developmental Treatment of Autism
Volume: 7 Issue: 2
Author(s): D. I. Zafeiriou, A. Ververi and E. Vargiami
Affiliation:
Keywords: Autism, serotonin, serotonergic, developmental intervention, plasticity, 5-hydroxytryptophan
Abstract: Autism is a severe childhood disorder already presenting in the first 3 years of life and, therefore, strongly correlated with neurodevelopmental alterations in prenatal, as well as postnatal period. Neurotransmitters hold a pivotal role in development by providing the stimulation needed for synapses and neuronal networks to be formed during the critical period of neuroplasticity. Aberrations of the serotonergic system modify key processes in the developing brain and are strongly implicated in the pathophysiology of developmental disorders. Evidence for the role of serotonin in autism emerges from neuropathological, imaging and genetic studies. Due to its developmental arrest, autism requires early intervention that would, among others, target the disrupted serotonergic system and utilize brain plasticity to elicit clinically important brain changes in children.
Export Options
About this article
Cite this article as:
Zafeiriou I. D., Ververi A. and Vargiami E., The Serotonergic System: Its Role in Pathogenesis and Early Developmental Treatment of Autism, Current Neuropharmacology 2009; 7 (2) . https://dx.doi.org/10.2174/157015909788848848
DOI https://dx.doi.org/10.2174/157015909788848848 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Cross-talk between Tristetraprolin and Cytokines in Cancer
Anti-Cancer Agents in Medicinal Chemistry Delivery of Therapeutic Proteins: Challenges and Strategies
Current Drug Targets Myofascial Temporomandibular Disorder
Current Rheumatology Reviews Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets Proton Pump Inhibitors in Pediatrics: Evaluation of Efficacy in GERD Therapy
Current Clinical Pharmacology Recent Approaches in Chemoprevention of Prostate Cancer
Current Cancer Drug Targets Evaluation of Isolated Fractions of Aloe vera Gel Materials on Indinavir Pharmacokinetics: In vitro and in vivo Studies
Current Drug Delivery Patent Selections
Recent Patents on Anti-Infective Drug Discovery Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
Current Pharmaceutical Design The Attentional Set-Shifting Test Paradigm in Rats for the Screening of Novel Pro-Cognitive Compounds with Relevance for Cognitive Deficits in Schizophrenia
Current Pharmaceutical Design Inflammatory Responses in Brain Ischemia
Current Medicinal Chemistry Epidemiology of Major Congenital Malformations with Specific Focus on Teratogens
Current Drug Safety Molecular Genetics and Epidemiology of Osteoporosis
Current Pharmacogenomics Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area
Current Psychiatry Reviews Role of Bactericidal/Permeability-Increasing Protein (BPI) in Sepsis and Liver Cirrhosis, and Its Clinical Implications
Anti-Infective Agents The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypertension, Prehypertension and Blood Pressure Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cystatin C, Adipokines and Cardiovascular Risk in HIV Infected Patients
Current HIV Research Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification
Cardiovascular & Hematological Disorders-Drug Targets Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design